Mano, Miguel
Claim profile
Loading...
2
0
20
0
false
Credit Name
Mano, Miguel
Name
Mano, Miguel
Variants
Mano, Miguel
Mano, M.
Mano, M.
Unidade de I&D
Personal Site
http://www.cnbc.pt/research/department_group_show.asp?iddep=1106&idgrp=1296&idseccao=38
Email
mano@ci.uc.pt
Ciência ID
Scopus Author ID
Researcher ID
Status
UC Researcher
Biography
Miguel Mano graduated in Biochemistry from the University of Coimbra, Portugal, and obtained a PhD degree in Biochemistry from the University of Coimbra, Portugal, in 2006. After the PhD, M. Mano worked as a Post-Doctoral fellow (2006-2008) at the Molecular Medicine laboratory at the International Centre for Genetic Engineering and Biotechnology (ICGEB, Trieste, Italy). Starting in 2008, M. Mano has taken the position of Scientific Manager of the High-Throughput Screening Facility at the ICGEB (Trieste, Italy), the first established in an academic research laboratory in Italy. In 2011, M. Mano became Staff Research Scientist at the ICGEB.
In 2014, Miguel Mano established an independent laboratory at the Centre for Neuroscience and Cell Biology (CNC, Coimbra, Portugal), under the “FCT Investigator Programme” from the Portuguese Science Foundation (FCT, Portugal) and in 2018 M. Mano became Principal Investigator at CNC. Since 2020, M. Mano is Assistant Professor at the Department of Life Sciences at the University of Coimbra.
The ‘Functional Genomics and RNA-based Therapeutics’ laboratory, headed by Miguel Mano, hosts a state-of-the-art high-throughput screening platform equipped with adequate instrumentation, libraries and expertise to perform genome-wide siRNA and microRNA and CRISPR screenings in human and mouse cellular models.
The research of the ‘Functional Genomics and RNA-based Therapeutics’ laboratory is focused on two main areas: i) the identification and molecular characterization of novel cellular factors relevant to cardiac repair and regeneration, and the translation of this knowledge into effective RNA-based therapeutic strategies, and ii) the development of high-throughput and high-content screening technologies genome-wide siRNA, CRISPR and microRNA libraries.
M. Mano has published 50 papers in international peer-reviewed journals, including papers in high impact factor journals (Nature, Nature Cell Biology, PNAS, Nature Communications, Nature Microbiology, Cancer Cell), which received over 2600 citations; h-index 22. M. Mano is also a co-inventor of 2 patents related to the clinical development of miRNAs for cardiovascular diseases.
M. Mano has received PhD and Post-Doctoral fellowships from the Portuguese Science Foundation (FCT). In 2011 he has been awarded the prestigious Excellence in Research Award from the American Society for Gene and Cell Therapy (ASGCT).
M. Mano has obtained funding, as Principal Investigator, from different funding agencies (total funding exceeding 650,000€ since July 2014).
In 2014, Miguel Mano established an independent laboratory at the Centre for Neuroscience and Cell Biology (CNC, Coimbra, Portugal), under the “FCT Investigator Programme” from the Portuguese Science Foundation (FCT, Portugal) and in 2018 M. Mano became Principal Investigator at CNC. Since 2020, M. Mano is Assistant Professor at the Department of Life Sciences at the University of Coimbra.
The ‘Functional Genomics and RNA-based Therapeutics’ laboratory, headed by Miguel Mano, hosts a state-of-the-art high-throughput screening platform equipped with adequate instrumentation, libraries and expertise to perform genome-wide siRNA and microRNA and CRISPR screenings in human and mouse cellular models.
The research of the ‘Functional Genomics and RNA-based Therapeutics’ laboratory is focused on two main areas: i) the identification and molecular characterization of novel cellular factors relevant to cardiac repair and regeneration, and the translation of this knowledge into effective RNA-based therapeutic strategies, and ii) the development of high-throughput and high-content screening technologies genome-wide siRNA, CRISPR and microRNA libraries.
M. Mano has published 50 papers in international peer-reviewed journals, including papers in high impact factor journals (Nature, Nature Cell Biology, PNAS, Nature Communications, Nature Microbiology, Cancer Cell), which received over 2600 citations; h-index 22. M. Mano is also a co-inventor of 2 patents related to the clinical development of miRNAs for cardiovascular diseases.
M. Mano has received PhD and Post-Doctoral fellowships from the Portuguese Science Foundation (FCT). In 2011 he has been awarded the prestigious Excellence in Research Award from the American Society for Gene and Cell Therapy (ASGCT).
M. Mano has obtained funding, as Principal Investigator, from different funding agencies (total funding exceeding 650,000€ since July 2014).
Loading...
3
0
20
0
false
Publications
(All)
Results 1-1 of 1 (Search time: 0.004 seconds).
| Issue Date | Title | Author(s) | Type | Access | |
|---|---|---|---|---|---|
| 1 | 10-Feb-2006 | Péptidos permeantes como sistemas promissores para transporte de ácidos nucleicos : mecanismos de internalização celular e actividade biológica do péptido S413-PV | Mano, Miguel Luís Cunha | doctoralThesis | embargoedAccess |